CF, India, CFTR mutations, Genetics
oral cavity squamous cell carcinoma (OSCC), borderline resectable, neoadjuvant therapy, nivolumab, oral metronomic therapy, pathological response
healthcare utilisation, COVID-19, private hospitals, interrupted time-series analysis, hospital finances